From therapeutic promise to evidentiary discipline: Reassessing MDMA-assisted psychotherapy for posttraumatic stress disorder.
Journal of traumatic stress June 1, 2026 Kadek Suhardita, Veno Dwi Krisnanda, Rikas Saputra et al.
MDMA-assisted psychotherapy shows promise for treating PTSD, but the evidence base has major limitations: difficulties in blinding, expectancy effects, lack of active comparators, unclear mechanisms, and safety concerns. The commentary argues these issues are central to interpreting the therapy's effects and future translation. It calls for moving beyond symptom reduction to broader recovery indicators like functioning, quality of life, relational restoration, and long-term durability. Stronger attention to equity, scalability, therapist training, and ethical safeguards is needed, especially for global mental health frameworks. The discussion aims to stimulate deeper debate on evaluating innovation in trauma treatment before widespread clinical adoption.